Primary endpoint analysis of the GEPARDUO study: Comparing dose-dense with sequential adriamycin/docetaxel combination as preoperative chemotherapy (PCHT) in operable breast cancer (T2-3, N0-2, M0)
- 31 March 2003
- journal article
- abstracts
- Published by Elsevier in The Breast
- Vol. 12, S37
- https://doi.org/10.1016/s0960-9776(03)80118-2
Abstract
No abstract availableKeywords
This publication has 0 references indexed in Scilit: